LALudmilla Pinto Guiotti Cintra Abreu

Ludmilla Pinto Guiotti Cintra Abreu

*This is an algorithmically generated author record based on publicly available information.

Ludmilla Pinto Guiotti Cintra Abreu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Technological Prospection and Scientific Evidence of the Antimicrobial Activity of Bixa orellana: An Integrative Review

    by Brenda de S. Moreno, Ludmilla P. G. C. Abreu, Gabriella de O. Silva, Lucas M. Syllos, Jhenyfer B. dos Santos, Ronaldo G. Abreu, Patrícia O. de Andrade, Graziella A. Joanitti, Marcella L. B. Carneiro

  • Open Access

    Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia

    by Glécia Virgolino da Silva Luz, Ludmilla Pinto Guiotti Cintra Abreu, Nashira Vieira O’REilly Cabral Posada, Ronaldo Gonçalves Abreu, Gleide Célia Virgolino da Silva, Graziella Anselmo Joanitti, Marcella Lemos Brettas Carneiro

    Introduction: Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction. Objective: To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials. Method: A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks. Results: Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy. Conclusions: There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.